Abstract 2201: The molecular signature of tumor cells that are sensitives to a new tight binder NAMPT inhibitor.Sandrine Hilairet, Monsif Bouaboula, Annick Péleraux et al.|Cancer Research|2013Cited by 0
Abstract 5775: Identification of SAR439859, an orally bioavailable selective estrogen receptor degrader (SERD) that has strong anti-tumor activity in wild-type and mutant ER+ breast cancer modelsMaysoun Shomali, Monsif Bouaboula, Youssef El‐Ahmad et al.|Cancer Research|2018Cited by 0